S. Nadar

发表

Short sleep duration and the risk of hypertension: snoozing away high blood pressure?

Ashish Kumar, Harsh Goel, S. Nadar, 2019, Journal of Human Hypertension.

The mercury sphygmomanometer: soon a museum piece!

S. Nadar, H. Al-Riyami, 2020, Journal of Human Hypertension.

Troponin Testing in the Emergency Department: Real world experience.

Hafidh A Al-Hadi, S. Nadar, M. Al-Maskari, 2018, Sultan Qaboos University medical journal.

Tilt-table test: its role in modern practice.

J. Panting, S. Nadar, K. Sandhu, 2013, Clinical medicine.

Biomarkers in Routine Heart Failure Clinical Care

S. Nadar, M. M. Shaikh, Mohammad Mujtaba Shaikh, 2018, Cardiac failure review.

Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study

G. Lip, H. Lim, D. Beevers, 2002, Journal of Human Hypertension.

New insights into complement C3 and inflammation in hypertension

G. Lip, S. Nadar, 2007, Journal of Human Hypertension.

Platelet adhesion in hypertension: Application of a novel assay of platelet adhesion

G. Lip, A. Blann, G. Caine, 2005, Annals of medicine.

Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke

G. Lip, A. Blann, S. Nadar, 2004, Thrombosis and Haemostasis.

Pharmacological Modulation of Platelet Function in Hypertension

G. Lip, A. Blann, S. Nadar, 2003, Hypertension.

Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.

G. Lip, R. Macfadyen, S. Nadar, 2009, Cardiovascular therapeutics.

Ongoing trials involving angiotensin-converting enzyme inhibitors

G. Lip, S. Nadar, 2002, Expert Opinion on Investigational Drugs.

May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

P. López-Jaramillo, D. Prabhakaran, E. O’Brien, 2019, European heart journal.

The heart in hypertension

G. Lip, S. Nadar, 2020, Journal of Human Hypertension.

Abnormal angiopoietins 1&2, angiopoietin receptor Tie‐2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT)]

G. Lip, A. Blann, D. Beevers, 2005, Journal of internal medicine.

Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role.

G. Lip, S. Nadar, 2003, Stroke.

Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.

A. Blann, G. Lip, S. Nadar, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Successful use of intra-aortic counter pulsation therapy for intractable ventricular arrhythmia in patient with severe left ventricular dysfunction and normal coronary arteries.

P. Banerjee, B. Wrigley, S. Nadar, 2010, Cardiology journal.

Temperature, cardiovascular mortality, and the role of hypertension and renin–angiotensin–aldosterone axis in seasonal adversity: a narrative review

Harsh Goel, S. Nadar, K. Shah, 2022, Journal of Human Hypertension.

Prevalence of high blood pressure and cardiovascular risk factors from a community screening programme in the Middle-East; a 3-year analysis of data from the May Measurement Month programme (2017–2019) in Oman

N. Poulter, T. Beaney, S. Nadar, 2021, Journal of Human Hypertension.

Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.

G. Lip, Jeetesh V. Patel, Hoong Sern Lim, 2005, The American journal of cardiology.

Fondaparinux: an overview

G. Lip, E. Shantsila, S. Nadar, 2009, Expert review of cardiovascular therapy.

Aspirin and endothelial function in hypertension

G. Lip, S. Nadar, D. Felmeden, 2005, Journal of Human Hypertension.

Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

G. Lip, A. Blann, D. Beevers, 2004, Journal of the American College of Cardiology.

Awareness of the Dangers of High Salt Intake among the Urban Omani Population

K. Al-Hashmi, S. Nadar, H. Al-Riyami, 2020, Sultan Qaboos University medical journal.

Patients' understanding of anticoagulant therapy in a multiethnic population.

G. Lip, B. Kaur, N. Begum, 2003, Journal of the Royal Society of Medicine.

Patients’ Understanding of Anticoagulant Therapy in a Multiethnic Population

G. Lip, B. Kaur, N. Begum, 2003 .

What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure.

S. Nadar, Osama Tariq, 2018, Cardiac failure review.

Spotlight on hypertension in the Indian subcontinent

S. Nadar, 2019, Journal of Human Hypertension.

Platelet activation in pregnancy-induced hypertension.

G. Lip, A. Blann, S. Nadar, 2005, Thrombosis research.

Plasma markers of angiogenesis in pregnancy induced hypertension

A. Blann, G. Lip, S. Nadar, 2005, Thrombosis and Haemostasis.

Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.

G. Lip, A. Blann, S. Nadar, 2004, Thrombosis research.

DIASTOLIC DYSFUNCTION IN HYPERTENSIVES AS ASSESSED BY TISSUE DOPPLER; RELATION TO MATRIX METALLOPROTEINASES

G. Lip, S. Nadar, M. Tayebjee, 2004 .

Delays in Presentation by Patients with ST Elevation Myocardial Infarction

S. Nadar, Adil Al-Riyami, Suhaib Almashari, 2021, Sultan Qaboos University medical journal.

Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis

G. Lip, Jeetesh V. Patel, Hoong Sern Lim, 2006, Journal of hypertension.

A single centre experience from Oman

W. Abdelmottaleb, S. Nadar, F. Alkindi, 2021 .

A single centre experience from Oman

W. Abdelmottaleb, S. Nadar, F. Alkindi, 2022 .

Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy

G. Lip, A. Blann, S. Nadar, 2004, Annals of medicine.

Platelet adhesion in breast cancer: development and application of a novel assay

G. Lip, A. Blann, G. Caine, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Circulating endothelial cells in acute ischaemic stroke

G. Lip, A. Blann, S. Nadar, 2005, Thrombosis and Haemostasis.

Determinants of Provision of Bystander Cardiopulmonary Resuscitation among the General Public in Oman

S. Nadar, H. Al-Riyami, A. Al-Hinai, 2020, Sultan Qaboos University medical journal.

Association between heart failure with preserved ejection fraction and hypertensive retinopathy: more questions than answers!

S. Nadar, 2018, Journal of Human Hypertension.

Ventricular interdependence in hypertension: fact or fiction?

S. Nadar, M. Tayebjee, I. F. H. A. Elsisi, 2019, Journal of Human Hypertension.

Tissue inhibitor of metalloproteinse‐1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension

G. Lip, H. Lim, S. Nadar, 2005, European journal of clinical investigation.

Target organ damage in hypertension: pathophysiology and implications for drug therapy.

G. Lip, F. Messerli, S. Nadar, 2006, Current pharmaceutical design.

Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.

G. Lip, D. Beevers, R. Macfadyen, 2005, American Journal of Hypertension.

Cardiac involvement in beta-thalassaemia: current treatment strategies

A. Taher, M. Refaat, V. Thomson, 2019, Postgraduate medicine.

Epidemiological studies in hypertension: more relevant than ever

S. Nadar, 2016, Journal of Human Hypertension.

Endothelial dysfunction: methods of assessment and application to hypertension.

G. Lip, A. Blann, S. Nadar, 2004, Current pharmaceutical design.

New evidence of anti-inﬂammatory interventions in atrial ﬁbrillation:

S. Nadar, 2006 .

Managing hypertension during the COVID-19 pandemic

M. Stowasser, J. B. Byrd, S. Nadar, 2020, Journal of Human Hypertension.

Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.

G. Lip, R. Macfadyen, S. Nadar, 2004, American journal of hypertension.

Symptomatic Hypertrophic Obstructive Cardiomyopathy

S. Nadar, A. A. Riyami, H. A. Lawati, 2022 .

The deleterious effect of intracardiac pacing leads on right ventricular function

S. Nadar, Muhammad Mujtaba Shaikh, Sheikha Al Jabri, 2021, Qatar medical journal.

Platelet activation in the hypertensive disorders of pregnancy

G. Lip, S. Nadar, 2004, Expert opinion on investigational drugs.

Case report: An unusual complication of clopidogrel.

M. Gunning, S. Nadar, C. Mavroudis, 2007, International journal of cardiology.

Estimation of Salt Intake and its Relation to Knowledge and Attitude Regarding the Dangers of High Salt Intake among an Urban Omani Population

S. Nadar, K. Alhashmi, Muhammad M. Shaikh, 2021, Sultan Qaboos University medical journal.

Transient contrast induced neurotoxicity after coronary angiography: A contrast re-challenge case

S. Nadar, M. Sadiq, M. Shaikh, 2020, Pakistan journal of medical sciences.

The prothrombotic state in hypertension and the effects of antihypertensive treatment.

G. Lip, S. Nadar, 2003, Current pharmaceutical design.

Hypertension and the prothrombotic state.

G. Lip, S. Nadar, 2003, Journal of the American College of Cardiology.

Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy

H. Al Lawati, S. Nadar, Adil B Al Riyami, 2022, Sultan Qaboos University medical journal.

Patients With Aortic Stenosis and Severe Pulmonary Hypertension

S. Nadar, 2016 .

Use of Intracoronary Thrombolysis for Huge Thrombus Burden in an Ectatic Right Coronary Artery

H. Alhadi, S. Nadar, Hatim Al-Lawati, 2020, Sultan Qaboos University medical journal.

Gastric carcinoma as a complication of dyskeratosis congenita in an adolescent boy

M. Mathan, D. Mathai, S. Nadar, 1996, Digestive Diseases and Sciences.

Abnormal diastolic function and Global longitudinal strain in patients with Thalassemia Major on long term chelation therapy

S. Daar, W. Abdelmottaleb, S. Nadar, 2020, The International Journal of Cardiovascular Imaging.

Spotlight on hypertension in the Middle-East

S. Nadar, H. Al-Riyami, 2022, Journal of Human Hypertension.

The adhesion molecule P-selectin and cardiovascular disease.

Gregory Y H Lip, G. Lip, A. Blann, 2003, European heart journal.

Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.

G. Lip, A. Blann, S. Nadar, 2006, American journal of hypertension.

Do heart failure patients understand their diagnosis or want to know their prognosis? Heart failure from a patient's perspective.

P. Banerjee, S. Nadar, D. Goyal, 2010, Clinical medicine.

Percutaneous coronary intervention in the elderly.

S. Nadar, K. Sandhu, 2015, International journal of cardiology.

Evaluation of the aortic root with MRI and MDCT angiography: spectrum of disease findings.

G. Gulati, E. Hoey, A. Ganeshan, 2012, AJR. American journal of roentgenology.

Management of elderly patients with troponin positive chest pain in a district general hospital.

S. Nadar, K. Sandhu, Avtar Singh, 2012, Cardiology journal.

Plasma and platelet‐derived vascular endothelial growth factor and angiopoietin‐1 in hypertension: effects of antihypertensive therapy

G. Lip, A. Blann, S. Nadar, 2004, Journal of internal medicine.

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

G. Lip, A. Blann, R. Macfadyen, 2004, American journal of hypertension.

Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis.

Gregory Y H Lip, G. Lip, R. Taylor, 2005, International journal of cardiology.

Secular trends in cardiovascular disease

G. Lip, S. Nadar, 2002, Journal of Human Hypertension.

Epidemiology, Outcomes and Coronary Angiography Findings of Patients Following Out-of-Hospital Cardiac Arrest: A single-centre experience from Oman.

Hafidh A Al-Hadi, S. Nadar, Hatim Al-Lawati, 2018, Sultan Qaboos University medical journal.

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension: relationship to cardiovascular risk and treatment

G. Lip, A. Blann, D. Beevers, 2004 .

New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion?

S. Nadar, 2017, Sultan Qaboos University medical journal.

Heart-type fatty acid-binding protein: an overlooked cardiac biomarker

G. Lip, Ashish Kumar, Harsh Goel, 2020, Annals of medicine.

Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease

G. Lip, A. Blann, A. Chong, 2005, Thrombosis and Haemostasis.

Implications of the LIFE trial

G. Lip, Hoong Sern Lim, S. Nadar, 2003, Expert opinion on investigational drugs.

Genes and Cardiovascular Disease: Where do we go from here?

S. Nadar, K. Sandhu, 2015, Sultan Qaboos University medical journal.

New guidelines with few takers: will the new American guidelines ever be accepted?

M. Stowasser, S. Nadar, 2018, Journal of Human Hypertension.

Knowledge Regarding Secondary Prevention Lifestyle Practices Among Patients with Ischaemic Heart Disease in Oman: Pilot study.

S. Nadar, T. Al-Tamimi, Hafidh Ba-Omar, 2017, Sultan Qaboos University medical journal.

Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?

V. Karthikeyan, S. Nadar, A. Mezincescu, 2018, Sultan Qaboos University medical journal.

Echocardiographic changes in patients with malignant phase hypertension: The West Birmingham Malignant Hypertension Register

G. Lip, D. Beevers, S. Nadar, 2005, Journal of Human Hypertension.

Antihypertensive therapy and endothelial function.

G. Lip, A. Blann, S. Nadar, 2004, Current pharmaceutical design.

Adherence to Medications in Patients with Ischemic Heart Disease in Oman

S. Nadar, A. Al-Maskari, Qasim Al-Maamari, 2023, Sultan Qaboos University Medical Journal.

Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time.

S. Nadar, M. M. Shaikh, 2019, Cardiac failure review.

Aiming higher in hopes to achieve lower: the European Society of Cardiology/European Society of Hypertension versus the American College of Cardiology/American Heart Association guidelines for diagnosis and management of hypertension

Harsh Goel, S. Nadar, H. Tayel, 2019, Journal of Human Hypertension.

Estimation of Salt Intake and its Relation to Knowledge and Attitude 7 Regarding the Dangers of High Salt Intake Among an Urban Omani 8 Population A pilot study

S. Nadar, K. Alhashmi, Muhammad M. Shaikh, 2021 .

Comparison between two protocols for deflation of the TR band following coronary procedures via the radial route

S. Nadar, A. A. Riyami, H. Riyami, 2019, Journal of the Saudi Heart Association.

Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role.

L. Cupini, R. Simone, G. Lip, 2003, Stroke.

Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review

Harsh Goel, S. Nadar, M. Carey, 2023, Journal of cardiovascular pharmacology.

Yield of Cardiac Investigations in Patients Presenting with Acute Ischaemic Stroke

A. Gujjar, H. Al Lawati, S. Nadar, 2022, Sultan Qaboos University medical journal.

Compliance and the treatment of hypertension: where are we now?

G. Lip, S. Nadar, 2007 .

Inflammation and hypertension: more evidence but is there anything new?

S. Nadar, D. Goyal, 2020, Journal of Human Hypertension.